Talking siRNAs with the CEO of Silence Therapeutics
- blonca9
- Feb 26, 2024
- 1 min read
Craig Tooman describes Silence's two lead programs targeting Lp(a) and polycythemia vera, as well as how the company is trying to execute on a broader platform.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
bottom of page